Clinical Trial Phase Analysis Data: How Pharma Teams Benchmark Pipelines Faster

A pharma competitive intelligence team needs to benchmark competitor pipelines by phase and therapeutic area. They pull ClinicalTrials.gov data. Two weeks later, they are still cleaning it.

Sponsor names are inconsistent. Phase classifications vary. Data formats shift between downloads. The analysis that should take days takes months.

This is not a skills problem. It is a data normalization problem. And it costs pharma data teams thousands of engineering hours every year.

The Real Cost of Raw ClinicalTrials.gov Data

ClinicalTrials.gov is the definitive public source for clinical trial information. Over 450,000 studies. Global coverage. Free to access.

But free does not mean ready to use.

Raw ClinicalTrials.gov exports arrive with inconsistent sponsor naming. Pfizer appears as “Pfizer”, “Pfizer Inc.”, “Pfizer Inc”, and “Pfizer, Inc.” in the same dataset. Phase fields contain free text that requires manual mapping. Therapeutic area classifications are incomplete or missing entirely.

Before any competitive intelligence work can begin, a data engineer must normalize sponsor names, standardize phase classifications, and map therapeutic areas to a consistent taxonomy.

This is not analysis. This is data janitorial work. And it repeats every time the data refreshes.

What Clinical Trial Phase Analysis Data Actually Requires

Pipeline benchmarking depends on three things:

• Accurate phase classification. Knowing exactly which trials are in Phase 1, Phase 2, Phase 3, or Phase 4 across your competitive set.
• Consistent sponsor identification. Rolling up all trials to the correct parent company, regardless of how the sponsor name was entered.
• Therapeutic area mapping. Filtering trials by indication, disease area, or mechanism of action to focus analysis.

Raw ClinicalTrials.gov data fails on all three. The schema is designed for regulatory compliance, not competitive analysis.

Pharma data teams that build their own normalization pipelines spend weeks on initial ingestion. Then they spend more time maintaining the pipeline as source formats change. Then they discover edge cases that break their logic six months later.

The total cost of self-service clinical trial data normalization often exceeds the cost of a production-ready dataset by a factor of ten or more.

How AACT Solves the Normalization Problem

AACT is the normalized, structured version of ClinicalTrials.gov data. It lands in your Snowflake environment ready to query. No ingestion pipeline. No cleaning sprint. No schema surprises.

Sponsor names are normalized to parent companies. Phase classifications follow a consistent standard. Therapeutic areas and conditions are mapped to queryable fields.

A competitive intelligence analyst can run a phase distribution query on the first day, not the first month.

This is what production-ready clinical trial phase analysis data looks like:

• Join directly to internal tables. AACT data shares a Snowflake-native schema that integrates with your existing data architecture.
• Refresh automatically. No manual downloads. No ETL maintenance. Data stays current without engineering intervention.
• Query immediately. Phase, sponsor, condition, intervention type, enrollment, and outcome fields are all structured for analysis.

[INTERNAL LINK: AACT dataset listing page with full schema documentation]

Pipeline Benchmarking Use Cases

Pharma and biotech teams use AACT for clinical trial phase analysis across several workflows:

Competitive pipeline tracking. How many Phase 3 trials does a competitor have in oncology? What therapeutic areas are they expanding into? Where have they paused or terminated trials?

R&D investment analysis. Which indications are attracting the most trial activity? Where is the industry investing, and where is it pulling back?

BD and M&A due diligence. Before acquiring a biotech, what does their clinical pipeline actually look like? How do their phase distributions compare to the market?

Portfolio benchmarking. How does your own pipeline compare to competitors by phase, therapeutic area, and trial volume?

Teams at Roche, Amgen, AstraZeneca, and Sumitovant use AACT for exactly these workflows. So do healthcare consultancies like ZS and Deloitte when they support pharma clients on competitive intelligence engagements.

Why Snowflake Changes the Procurement Model

Traditional external data procurement looks like this: negotiate a contract, receive a data dump, build an ingestion pipeline, clean the data, load it into your warehouse, maintain the pipeline as formats change.

Snowflake Marketplace changes the model entirely.

AACT data is available as a live data share. It lands in your Snowflake environment with no file transfer, no ETL, and no maintenance. When the source updates, your data updates. When you need to query, you query.

Snowflake sales engineers demo AACT to their life sciences prospects because it shows what Snowflake-native external data actually looks like. If you are evaluating Snowflake for healthcare or pharma analytics, AACT is often part of the conversation.

[INTERNAL LINK: Guide to accessing Element Data datasets on Snowflake Marketplace]

The Competitive Advantage of Normalized Data

Pharma teams that use normalized clinical trial phase analysis data do not just save engineering time. They respond faster.

When a competitor announces a Phase 3 readout, they can pull context in hours, not weeks. When leadership asks for a pipeline comparison, they deliver it the same day. When BD needs trial data for a target company, the query is ready before the meeting.

This is not about having more data. It is about having data that is ready to use when the business needs it.

A normalized AACT dataset is not a convenience. It is a competitive advantage measured in speed, accuracy, and engineering hours reclaimed.

Frequently Asked Questions

Where can I find normalized clinical trial data for competitive analysis?

Element Data provides AACT, a normalized version of ClinicalTrials.gov data, available directly on Snowflake Marketplace. The dataset includes standardized sponsor names, phase classifications, and therapeutic area mappings ready for pipeline benchmarking and competitive intelligence.

How often is AACT data refreshed?

AACT data is refreshed regularly to reflect updates from ClinicalTrials.gov. Because it is delivered as a Snowflake data share, refreshes happen automatically without requiring any pipeline maintenance on your side.

Can I join AACT data to my internal clinical or commercial datasets?

Yes. AACT data is structured with a Snowflake-native schema designed to join directly to internal tables. Common join patterns include sponsor-level rollups, therapeutic area filters, and phase-based segmentation.

What pharma companies use AACT for pipeline benchmarking?

Teams at Roche, Amgen, AstraZeneca, Sumitovant, and other pharma and biotech companies use AACT for competitive intelligence and pipeline analysis. Healthcare consultancies like ZS and Deloitte also use it to support client engagements.

How does AACT compare to raw ClinicalTrials.gov downloads?

Raw ClinicalTrials.gov exports require significant normalization before analysis. Sponsor names are inconsistent, phase fields contain free text, and therapeutic area mappings are incomplete. AACT delivers this normalization already completed, saving weeks of data engineering effort.

Ready to benchmark pipelines without the normalization tax? Request access to AACT on the Snowflake Marketplace and start querying clinical trial phase data today.